论文部分内容阅读
为了阐明导致急性髓性白血病(AML)的机制、找到敏感标志和药物治疗的新靶点、允许每个受累的个体选择合适的化疗,日本的Unoki M等用cDNA微阵列的方法比较了AML患者与正常对照之间mRNA的表达。
To elucidate the mechanisms that lead to acute myeloid leukemia (AML), find new hallmarks of sensitive markers and drug treatments that allow each affected individual to select the appropriate chemotherapy, and Japan’s Unoki M et al. Compared AML patients with cDNA microarray And normal control mRNA expression.